Last updated on February 2019

AMPLATZER PFO Occluder Post Approval Study

Brief description of study

The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER PFO Occluder in the post Approval Setting.

Detailed Study Description

A maximum of 1214 adult subjects will be enrolled at up to 100 centers in the U.S. and Canada. Subjects will have follow-up at 1 month, 6 months, 12 months and annually thereafter through 5 years post implant.

Clinical Study Identifier: NCT03309332

Contact Investigators or Research Sites near you

Start Over

James Jenkins, MD

Ochsner Medical Center
New Orleans, LA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.